济川药业：2025年半年度归属于上市公司股东的净利润为724364011.18元

Core Points - The company reported a significant decline in revenue and net profit for the first half of 2025, with revenue amounting to 2,748,717,966.21 yuan, representing a year-on-year decrease of 31.87% [2] - The net profit attributable to shareholders of the listed company was 724,364,011.18 yuan, reflecting a year-on-year decline of 45.87% [2] Financial Performance - Revenue for the first half of 2025: 2,748.72 million yuan, down 31.87% year-on-year [2] - Net profit for the first half of 2025: 724.36 million yuan, down 45.87% year-on-year [2]